Item | Medication | N | Postop 3 months | Postop 24 months | Diff | Between-Group p-value | Within-Group p-value | ||
---|---|---|---|---|---|---|---|---|---|
VAS | Forteo | 68 | 7.3 ± 0.9 | 2.8 ± 0.7 | -4.4 ± 1.2 | 0.020* | < 0.001* | ||
Prolia | 58 | 7.2 ± 0.9 | 4.2 ± 0.9 | -3.1 ± 1.1 | < 0.001* | ||||
Barthel scale | Forteo | 68 | 33.1 ± 9.9 | 80.3 ± 12.6 | 46.2 ± 7.5 | < 0.001* | < 0.001* | ||
Prolia | 58 | 38.8 ± 1.2 | 69.0 ± 1.1 | 31.2 ± 6.6 | < 0.001* | ||||
BMD Femur | Forteo | 68 | -3.0 ± 0.6 | -2.3 ± 0.6 | 0.7 ± 0.5 | 0.002* | < 0.001* | ||
Prolia | 58 | -3.1 ± 0.9 | -2.6 ± 0.7 | 0.5 ± 0.7 | < 0.001* | ||||
BMD L1-4 | Forteo | 68 | -3.1 ± 0.9 | -2.1 ± 1.3 | 0.9 ± 0.8 | 0.003* | < 0.001* | ||
Prolia | 58 | -3.2 ± 1.4 | -2.6 ± 1.3 | 0.6 ± 0.7 | < 0.001* |